How will the Health Care and Pharmaceutical sector deal with the long-term impacts of the pandemic as it relates to new and amended services agreements and terms? What new or increased risks have emerged and what does this mean in the context of the overall sourcing or contracting process?
This resource is only available to our paid members. You can Join Us or Sign in to get access to this resource.